Healthcare Market Research Reports & Industry Analysis

Healthcare refers to the field associated with maintaining or restoring patients’ health. These days’ Healthcare Industry falls into a lashing of discrete sub-sectors, and ancillary goods and services. Ranging from therapeutic equipment to medicinal drugs, medical tourism to sickness insurance, the Healthcare Market has been one of the most swiftly expanding sectors within the globe’s economic system.

Global Healthcare spending contributes close to 10% to the whole world’s GDP, though it varies noticeably with geography. Thus, the Western world’s average healthcare costs are far greater in contrast to those in the developing economies. North America alone is in charge of circa a half of the world’s overall spending on healthcare services. With budgets curtailments and growing costs, technology advances are increasingly taking a new meaning in the global Healthcare universe.

The research reports offer comprehensive insights into the market sizing, structure and dynamics of the Healthcare Industry based on various geographies, as well as in-depth market segmentation. The research reports incorporated in this Catalogue closely investigate the competition in the Healthcare Market, besides profiling countless market participants. Moreover, tomorrow's healthcare-related challenges are addressed, as well as projections into the future are provided in the research reports.

Publications found: 69,648
Sort by:

Somatotropin Deficiency Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major somatotropin deficiency markets are expected to exhibit a CAGR of 3.99% during 2024-2034. The somatotropin deficiency market has been comprehensively analyzed in IMARC's new report titled...

May 2024 133 pages

Sphingolipidoses Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major sphingolipidoses markets are expected to exhibit a CAGR of 4.01% during 2024-2034. The sphingolipidoses market has been comprehensively analyzed in IMARC's new report titled 'Sphingolipido...

May 2024 140 pages

Spina Bifida In Utero Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major spina bifida in utero markets are expected to exhibit a CAGR of 6.59% during 2024-2034. The spina bifida in utero market has been comprehensively analyzed in IMARC's new report titled 'Spi...

May 2024 129 pages

Spinal Cord Injury Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major spinal cord injury markets are expected to exhibit a CAGR of 4.06% during 2024-2034. The spinal cord injury market has been comprehensively analyzed in IMARC's new report titled 'Spinal Co...

May 2024 130 pages

Spinal Disorders Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major spinal disorders markets reached a value of US$ 5.1 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 7.1 Billion by 2034, exhibiting a growth rate (CAGR) of 3.09%...

May 2024 134 pages

Spinal Muscular Atrophy Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major spinal muscular atrophy markets reached a value of US$ 3.0 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 13.0 Billion by 2034, exhibiting a growth rate (CAGR)...

May 2024 129 pages

Spinal Stenosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major spinal stenosis markets reached a value of US$ 6.8 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 9.5 Billion by 2034, exhibiting a growth rate (CAGR) of 3.12%...

May 2024 131 pages

Spinocerebellar Ataxia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major spinocerebellar ataxia markets are expected to exhibit a CAGR of 7.45% during 2024-2034. The spinocerebellar ataxia market has been comprehensively analyzed in IMARC's new report titled 'S...

May 2024 140 pages

Spondylolisthesis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major spondylolisthesis markets reached a value of US$ 17.7 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 29.5 Billion by 2034, exhibiting a growth rate (CAGR) of 4....

May 2024 139 pages

Squamous Cell Carcinoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major squamous cell carcinoma markets reached a value of US$ 693.2 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1,402.7 Million by 2034, exhibiting a growth rate (C...

May 2024 138 pages

Stargardt Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Stargardt disease markets are expected to exhibit a CAGR of 22.82% during 2024-2034. The Stargardt disease market has been comprehensively analyzed in IMARC's new report titled 'Stargardt...

May 2024 129 pages

Status Epilepticus Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major status epilepticus markets reached a value of US$ 884 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1,338.0 Million by 2034, exhibiting a growth rate (CAGR) of...

May 2024 137 pages

Still's Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Still's disease markets are expected to exhibit a CAGR of 3.45% during 2024-2034. The Still's disease market has been comprehensively analyzed in IMARC's new report titled 'Still's Disease...

May 2024 128 pages

Stress Urinary Incontinence Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major stress urinary incontinence markets are expected to exhibit a CAGR of 6.14% during 2024-2034. The stress urinary incontinence market has been comprehensively analyzed in IMARC's new report...

May 2024 137 pages

Subdural Haematoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast ?2024-2034?

US$ 6,499.00

The 7 major subdural haematoma markets are expected to exhibit a CAGR of 3.61% during 2024-2034. The subdural haematoma market has been comprehensively analyzed in IMARC’s new report titled “Subdural...

May 2024 134 pages

Substance Use Disorder Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major substance use disorder markets reached a value of US$ 5.1 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 7.5 Million by 2034, exhibiting a growth rate (CAGR) of...

May 2024 136 pages

Surgical Site Infections Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major surgical site infections markets reached a value of US$ 664.9 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1,174.5 Million by 2034, exhibiting a growth rate (...

May 2024 135 pages

Swimmer's Shoulder/Impingement Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast ?2024-2034?

US$ 6,499.00

The 7 major swimmer's shoulder/impingement syndrome markets are expected to exhibit a CAGR of 5.7% during 2024-2034. The swimmer's shoulder/impingement syndrome market has been comprehensively analyze...

May 2024 137 pages

Synovial Sarcoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major synovial sarcoma markets reached a value of US$ 75.3 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 114.0 Million by 2034, exhibiting a growth rate (CAGR) of 3....

May 2024 137 pages

Synucleinopathies Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major synucleinopathies markets reached a value of US$ 661.9 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1,095.2 Million by 2034, exhibiting a growth rate (CAGR) o...

May 2024 131 pages

Systemic Juvenile Idiopathic Arthritis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major systemic juvenile idiopathic arthritis markets reached a value of US$ 900 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1,250 Million by 2034, exhibiting a gro...

May 2024 135 pages

Systemic Mastocytosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major systemic mastocytosis markets reached a value of US$ 256.1 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 455.5 Million by 2034, exhibiting a growth rate (CAGR)...

May 2024 134 pages

Systemic Sclerosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major systemic sclerosis markets reached a value of US$ 1.3 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 2.4 Billion by 2034, exhibiting a growth rate (CAGR) of 6.0...

May 2024 137 pages

T-Cell Non-Hodgkin Lymphoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major T-cell non-Hodgkin lymphoma markets are expected to exhibit a CAGR of 5.55% during 2024-2034. The T-cell non-Hodgkin lymphoma market has been comprehensively analyzed in IMARC's new report...

May 2024 129 pages

Tachycardia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major tachycardia markets reached a value of US$ 9.9 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 22.4 Billion by 2034, exhibiting a growth rate (CAGR) of 7.76% dur...

May 2024 135 pages

Takotsubo Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Takotsubo syndrome markets reached a value of US$ 178.6 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 295.6 Million by 2034, exhibiting a growth rate (CAGR) of...

May 2024 132 pages

Tardive Dyskinesia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major tardive dyskinesia markets reached a value of US$ 1.7 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 2.4 Billion by 2034, exhibiting a growth rate (CAGR) of 3.0...

May 2024 130 pages

Tauopathies Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major tauopathies markets reached a value of US$ 661.6 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1,493.0 Million by 2034, exhibiting a growth rate (CAGR) of 7.68...

May 2024 138 pages

Tay-Sachs Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Tay-Sachs disease markets are expected to exhibit a CAGR of 4.56% during 2024-20324. The Tay-Sachs disease market has been comprehensively analyzed in IMARC's new report titled 'Tay-Sachs...

May 2024 137 pages

TDP-43 Proteinopathies Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major TDP-43 proteinopathies markets reached a value of US$ 661.9 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 925.1 Million by 2034, exhibiting a growth rate (CAGR...

May 2024 131 pages

Telangiectasia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major telangiectasia markets are expected to exhibit a CAGR of 7.01% during 2024-2034. The telangiectasia market has been comprehensively analyzed in IMARC's new report titled 'Telangiectasia Ma...

May 2024 136 pages

Tendinopathy Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major tendinopathy markets reached a value of US$ 11.3 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 14.7 Billion by 2034, exhibiting a growth rate (CAGR) of 2.35% d...

May 2024 133 pages

Tendonitis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major tendonitis markets reached a value of US$ 11.5 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 15.6 Billion by 2034, exhibiting a growth rate (CAGR) of 2.78% dur...

May 2024 139 pages

Tenosynovitis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major tenosynovitis markets are expected to exhibit a CAGR of 4.25% during 2024-2034. The tenosynovitis market has been comprehensively analyzed in IMARC's new report titled 'Tenosynovitis Marke...

May 2024 137 pages

Testicular Neoplasm Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major testicular neoplasm markets reached a value of US$ 480.0 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 800.6 Million by 2034, exhibiting a growth rate (CAGR) o...

May 2024 128 pages

Tetanus Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major tetanus markets reached a value of US$ 1.1 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1.6 Billion by 2034, exhibiting a growth rate (CAGR) of 3.46% during 2...

May 2024 140 pages

Thalassemia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major thalassemia markets reached a value of US$ 2.0 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 3.0 Billion by 2034, exhibiting a growth rate (CAGR) of 3.84% duri...

May 2024 130 pages

Thrombocytopenia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major thrombocytopenia markets reached a value of US$ 3.2 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 5.2 Billion by 2034, exhibiting a growth rate (CAGR) of 4.5%...

May 2024 129 pages

Thrombotic Microangiopathies Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major thrombotic microangiopathies markets are expected to exhibit a CAGR of 3.76% during 2024-2034. The thrombotic microangiopathies market has been comprehensively analyzed in IMARC's new repo...

May 2024 134 pages

Thyroid Cancer Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major thyroid cancer markets reached a value of US$ 303.0 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1,624.3 Million by 2034, exhibiting a growth rate (CAGR) of 1...

May 2024 139 pages

Thyroid Eye Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major thyroid eye disease markets reached a value of US$ 2,122.9 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 4,139.7 Million by 2034, exhibiting a growth rate (CAG...

May 2024 131 pages

Tinnitus Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major tinnitus markets reached a value of US$ 1.8 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 2.3 Billion by 2034, exhibiting a growth rate (CAGR) of 2.02% during...

May 2024 129 pages

Tourette Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Tourette syndrome markets reached a value of US$ 1,818.1 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 2,710.2 Million by 2034, exhibiting a growth rate (CAGR)...

May 2024 135 pages

Trauma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major trauma markets are expected to exhibit a CAGR of 5.78% during 2024-2034. The trauma market has been comprehensively analyzed in IMARC's new report titled 'Trauma Market: Epidemiology, Indu...

May 2024 139 pages

Traumatic Brain Injury Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major traumatic brain injury markets are expected to exhibit a CAGR of 3.36% during 2024-2034. The traumatic brain injury market has been comprehensively analyzed in IMARC's new report titled 'T...

May 2024 128 pages

Traveler’s Diarrhea Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major traveler’s diarrhea markets are expected to exhibit a CAGR of 5.31% during 2024-2034. The traveler’s diarrhea market has been comprehensively analyzed in IMARC's new report titled 'Travele...

May 2024 134 pages

Treatment Resistant Depression Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major treatment resistant depression markets reached a value of US$ 3,295.3 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 6,286.7 Million by 2034, exhibiting a growt...

May 2024 139 pages

Trichotillomania Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major trichotillomania markets are expected to exhibit a CAGR of 6.5% during 2024-2034. The trichotillomania market has been comprehensively analyzed in IMARC's new report titled 'Trichotilloman...

May 2024 140 pages

Trigeminal Neuralgia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major trigeminal neuralgia markets reached a value of US$ 234.5 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 357.8 Million by 2034, exhibiting a growth rate (CAGR)...

May 2024 129 pages

Triple-negative Breast Cancer Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The triple-negative breast cancer market reached a value of US$ 490.5 Million across the top 7 markets (US, EU4, UK, and Japan) in 2023. Looking forward, IMARC Group expects the top 7 markets to reach...

May 2024 129 pages

Filters

Search

Categories

790
26
203
153
137
134
125
90
65,573
803
720
771
123

Publishers

179
1
158
389
103
453
148
425
3
202
3
6
1,620
487
76
123
208
1,842
111
25
212
1,049
370
23
40
68
472
277
34
29,954
248
501
3,036
1
1
2
3
16
239
536
361
1
1,357
60
1,696
8
8,921
2,215
4,532
321
66
3
36
200
29
29
143
42
83
3
281
85
20
6
43
14
1
178
48
359
36
44
10
11
18
168
297
8
3
18
58
900
6
89
13
24
15
1,285
227
128
386
3
74
10
119
231
46
474
25
133
4

Regions

92
58
45
43
41
31
30
30
29
28
28
28
21
16
16
16
14
12
12
10
10
10
9
8
8
8
7
7
7
7
7
6
6
6
6
6
6
6
6
6
6
6
6
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
787
495
2
2
2
117
191
102
53
23
700
26
133
522
174
622
64,679

Price

Date

Pages

Offers

1
280
1
1